"Recombinant Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins prepared by recombinant DNA technology.
| Descriptor ID |
D011994
|
| MeSH Number(s) |
D12.776.828
|
| Concept/Terms |
Recombinant Proteins- Recombinant Proteins
- Proteins, Recombinant
- Proteins, Biosynthetic
- Biosynthetic Proteins
Proteins, Recombinant DNA- Proteins, Recombinant DNA
- DNA Proteins, Recombinant
- Recombinant DNA Proteins
- DNA Recombinant Proteins
- Proteins, DNA Recombinant
- Recombinant Proteins, DNA
|
Below are MeSH descriptors whose meaning is more general than "Recombinant Proteins".
Below are MeSH descriptors whose meaning is more specific than "Recombinant Proteins".
This graph shows the total number of publications written about "Recombinant Proteins" by people in this website by year, and whether "Recombinant Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 63 | 63 |
| 1995 | 3 | 102 | 105 |
| 1996 | 4 | 94 | 98 |
| 1997 | 2 | 88 | 90 |
| 1998 | 2 | 95 | 97 |
| 1999 | 0 | 99 | 99 |
| 2000 | 1 | 96 | 97 |
| 2001 | 3 | 74 | 77 |
| 2002 | 2 | 98 | 100 |
| 2003 | 5 | 85 | 90 |
| 2004 | 3 | 102 | 105 |
| 2005 | 3 | 65 | 68 |
| 2006 | 2 | 77 | 79 |
| 2007 | 3 | 66 | 69 |
| 2008 | 3 | 60 | 63 |
| 2009 | 4 | 56 | 60 |
| 2010 | 6 | 42 | 48 |
| 2011 | 3 | 49 | 52 |
| 2012 | 5 | 38 | 43 |
| 2013 | 2 | 55 | 57 |
| 2014 | 1 | 32 | 33 |
| 2015 | 1 | 37 | 38 |
| 2016 | 6 | 31 | 37 |
| 2017 | 2 | 39 | 41 |
| 2018 | 4 | 21 | 25 |
| 2019 | 2 | 24 | 26 |
| 2020 | 2 | 24 | 26 |
| 2021 | 3 | 16 | 19 |
| 2022 | 0 | 7 | 7 |
| 2023 | 1 | 4 | 5 |
| 2024 | 3 | 3 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Recombinant Proteins" by people in Profiles.
-
Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children's Oncology Group AALL1931 study. Blood Adv. 2025 Jan 14; 9(1):66-77.
-
25th National and 11th International Annual Congress on Research and Technology of Iranian Medical Sciences Students, Urmia, Iran, 5-7 September, 2024 Iran Biomed J. 2024 12 01; 28(7):71.
-
Anti-stroke biologics: from recombinant proteins to stem cells and organoids. Stroke Vasc Neurol. 2024 Nov 05; 9(5):467-480.
-
Recombinant ADAMTS13: an effective rescue therapy for acute cTTP during pregnancy. Blood Adv. 2024 07 23; 8(14):3718-3720.
-
Loss of Dnmt3a increases self-renewal and resistance to pegIFN-a in JAK2-V617F-positive myeloproliferative neoplasms. Blood. 2024 06 13; 143(24):2490-2503.
-
Generation of a highly specific recombinant full-length antibody for detecting ethirimol in fruit and environmental water. J Hazard Mater. 2024 05 05; 469:134067.
-
Bivalirudin: The misunderstood alternative to heparin. Paediatr Anaesth. 2024 05; 34(5):394-395.
-
Retrospective Comparison of Recombinant Activated Factor VII Versus 4-Factor Prothrombin Complex Concentrate in Cardiac Surgical Patients. J Cardiothorac Vasc Anesth. 2024 Feb; 38(2):388-393.
-
Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial. Haematologica. 2023 10 01; 108(10):2730-2742.
-
Hematopoietic Stimulation During Impella 5.5 Support to Avoid Transfusions in a Jehovah's Witness. ASAIO J. 2023 08 01; 69(8):e384-e387.